RxNT Awarded ePrescribing Advanced Certification From Surescripts

* Reuters is not responsible for the content in this press release.

Mon Mar 30, 2009 3:29pm EDT 

  ANNAPOLIS, MD, Mar 30 (MARKET WIRE) -- 
RxNT, the nation's leader in electronic prescribing, today announced that
it is the only standalone ePrescribing solution to achieve 2008 Platinum
Solution Provider status from Surescripts for its RxNT Version 6.1.4
product.

    "Since May 1999 RxNT has been a leader in the advancement of ePrescribing
technology," states Randy Boldyga, CEO of RxNT. "Looking forward, we see
the company continuing to be an eHealth industry leader and our products
evolving to meet the expectations of our clients."

    Platinum or Gold Solution Provider status is granted by Surescripts to
vendors with software products that have gone beyond Surescripts baseline
product certification to meet benchmarks that demonstrate a higher level
of commitment to e-prescribing.

    Platinum Solution Provider status is granted to those companies that not
only meet the criteria for Gold Solution Provider status but also take the
initiative to become early adopters of next-generation network technology.
This includes participating in a pilot project aimed at developing new
approaches to further improve electronic prescribing.

    "An electronic connection between payers, prescribers and pharmacists is
essential to reducing costs and improving the safety and efficiency of a
prescribing process relied upon by millions of patients every day," said
JP Little and Rick Ratliff, co-CEOs of Surescripts. "For physicians
making an investment in the safety of their patients, the efficiency of
their practice and the quality of their own clinical decision making,
Platinum and Gold Solution Provider certification status helps them know
which software vendors are meeting the highest standards for
e-prescribing."

    About RxNT

    RxNT is a national electronic prescription provider located in Annapolis,
Maryland. Our high-caliber product reinforces patient safety by reducing
error, drug incompatibility issues, and illegibility. RxNT can be found at
www.rxnt.com or for more information please call us toll free at
800-943-RXNT.

    

Contact:
Megan Wake
RxNT
www.rxnt.com
Email Contact

Copyright 2009, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.